Filing Details

Accession Number:
0001548538-20-000027
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-08 21:04:04
Reporting Period:
2020-12-08
Accepted Time:
2020-12-08 21:04:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1671858 Silverback Therapeutics Inc. SBTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1474322 M Casey Tansey 1460 El Camino Real, Suite 100
Menlo Park CA 94025
No No Yes No
1734819 U.s. Venture Partners Xii, L.p. 1460 El Camino Real, Suite 100
Menlo Park CA 94025
No No Yes No
1734820 Presidio Management Group Xii, L.l.c. 1460 El Camino Real, Suite100
Menlo Park CA 94025
No No Yes No
1754875 U.s. Venture Partners Xii-A, L.p. 1460 El Camino Real, Suite 100
Menlo Park CA 94025
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-08 1,779,969 $0.00 1,779,969 No 4 C Indirect By U.S. Venture Partners XII, L.P.
Common Stock Acquisiton 2020-12-08 289,198 $0.00 2,069,167 No 4 C Indirect By U.S. Venture Partners XII, L.P.
Common Stock Acquisiton 2020-12-08 90,335 $0.00 90,335 No 4 C Indirect By U.S. Venture Partners XII-A, L.P.
Common Stock Acquisiton 2020-12-08 14,677 $0.00 105,012 No 4 C Indirect By U.S. Venture Partners XII-A, L.P.
Common Stock Acquisiton 2020-12-08 47,619 $21.00 47,619 No 4 P Indirect Directly owned by Tansey
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By U.S. Venture Partners XII, L.P.
No 4 C Indirect By U.S. Venture Partners XII, L.P.
No 4 C Indirect By U.S. Venture Partners XII-A, L.P.
No 4 C Indirect By U.S. Venture Partners XII-A, L.P.
No 4 P Indirect Directly owned by Tansey
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Preferred Series B Stock Disposition 2020-12-08 6,609,027 $0.00 1,779,969 $0.00
Common Stock Preferred Series B Stock Disposition 2020-12-08 335,417 $0.00 90,335 $0.00
Common Stock Preferred Series C Stock Disposition 2020-12-08 1,073,793 $0.00 289,198 $0.00
Common Stock Preferred Series C Stock Disposition 2020-12-08 54,496 $0.00 14,677 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The shares were purchased in the Issuer's initial public offering.
  2. Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock had no expiration date.
  3. Presidio Management Group XII, L.L.C. ("PMG XII"), the general partner of each of U.S. Venture Partners XII, L.P. and U.S. Venture Partners XII-A, L.P. (together, the "USVP XII Funds"), has sole voting and dispositive power with respect to the shares held by the USVP XII. Casey Tansey is the sole managing partner of PMG XII and may be deemed to have voting and dispositive power over the reported securities held by the USVP XII Funds, and each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.